EWING’S SARCOMA: APPROACHING CENTURY SINCE THIS BONE CANCER MADE NEWS
Ewing J. Neoplastic Diseases, a Text-book on Tumors: James Ewing... with 479 Illustrations. WB Saunders company; 1919.
Brand RA. Biographical sketch: James Stephen Ewing, MD (1844-1943). Clin Orthop Relat Res 2012;470:639-41.
Cripe TP. Ewing sarcoma: An eponym window to history. Sarcoma 2011;2011:4.
Desai SS, Jambhekar NA. Pathology of ewing’s sarcoma/PNET: Current opinion and emerging concepts. Indian J Orthop 2010;44:363-8.
Bellan DG, Filho RJ, Garcia JG, et al. Ewing’s sarcoma: Epidemiology and prognosis for patients treated at the pediatric oncology institute, IOP-GRAACC-UNIFESP. Rev Bras Ortop 2012;47:446-50.
Qureshi A, Ahmad Z, Azam M, et al. Epidemiological data for common bone sarcomas. Asian Pac J Cancer Prev 2010;11:393-5.
Bhurgri Y, Bhurgri H, Pervez S, et al. Epidemiology of soft tissue sarcomas in Karachi South, Pakistan (1995-7). Asian Pac J Cancer Prev 2008;9:709-14.
Badar F, Mahmood S. Epidemiology of cancers in Lahore, Pakistan, among children, adolescents and adults, 2010-2012: A cross-sectional study part 2. BMJ Open 2017;7:e016559.
Balamuth NJ, Womer RB. Ewing’s sarcoma. Lancet Oncol 2010;11:184-92.
Rodriguez-Galindo C. Ewing sarcoma and its many faces Are we close to a cure? Dev Period Med 2013;17:113-6.
Bailey K, Cost C, Davis I, et al. Emerging novel agents for patients with advanced ewing sarcoma: A report from the children’s oncology group (COG) new agents for Ewing sarcoma task force. F1000Res 2019;8:F1000.
Van Mater D, Wagner L. Management of recurrent Ewing sarcoma: Challenges and approaches. Onco Targets Ther 2019;12:2279-88.
Bajpai J, Khanna N, Vora T, et al. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at tata memorial hospital, Mumbai, with clinical outcomes. Indian J Cancer 2018;55:37-44.
Umer M, Ali M, Rashid RH, et al. Outcomes of internal hemipelvectomy for pelvic tumors: A developing country’s prospective. Int J Surg Oncol (N Y) 2017;2:e07.
Friedrich P, Ortiz R, Fuentes S, et al. Barriers to effective treatment of pediatric solid tumors in middle-income countries: Can we make sense of the spectrum of nonbiologic factors that influence outcomes? Cancer 2014;120:112-25.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.
Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.